Ekstranodalt marginalzonelymfom i øjets adnexa

Anders Møller; Lena Specht; Peter Bjerre Toft; Lene Dissing Sjø

Ekstranodalt marginalzonelymfom i øjets adnexa

Translated title of the contribution: [Extranodal marginal zone lymphoma of the ocular adnexa]

Anders Møller, Lena Specht, Peter Bjerre Toft, Lene Dissing Sjø

Abstract

Lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) is among the most common malignant lymphomas of the ocular adnexa and it furthermore shows an increasing incidence. The disease is most often localized and indolent of nature; gentle treatment is therefore of essence to avoid complications, especially visual impairment. MALT lymphoma can be treated with radiotherapy (RT), but in case of relapse, alternatives are required. New treatment modalities such as anti-cluster of differentiation (CD)-20 monoclonal antibodies (rituximab) and local injection of interferon-alpha have shown promising results.

Translated title of the contribution	[Extranodal marginal zone lymphoma of the ocular adnexa]
Original language	Danish
Journal	Ugeskrift for Laeger
Volume	170
Issue number	45
Pages (from-to)	3660-3
Number of pages	4
Publication status	Published - 3 Nov 2008

Cite this

@article{b1266a5f1c624b008a2f3c3e7ebf7b93,

title = "Ekstranodalt marginalzonelymfom i {\o}jets adnexa",

abstract = "Lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) is among the most common malignant lymphomas of the ocular adnexa and it furthermore shows an increasing incidence. The disease is most often localized and indolent of nature; gentle treatment is therefore of essence to avoid complications, especially visual impairment. MALT lymphoma can be treated with radiotherapy (RT), but in case of relapse, alternatives are required. New treatment modalities such as anti-cluster of differentiation (CD)-20 monoclonal antibodies (rituximab) and local injection of interferon-alpha have shown promising results.",

author = "Anders M{\o}ller and Lena Specht and Toft, \{Peter Bjerre\} and Sj{\o}, \{Lene Dissing\}",

year = "2008",

month = nov,

day = "3",

language = "Dansk",

volume = "170",

pages = "3660--3",

journal = "Ugeskrift for Laeger",

issn = "1399-4174",

publisher = "Almindelige Danske Laegeforening",

number = "45",

}

TY - JOUR

T1 - Ekstranodalt marginalzonelymfom i øjets adnexa

AU - Møller, Anders

AU - Specht, Lena

AU - Toft, Peter Bjerre

AU - Sjø, Lene Dissing

PY - 2008/11/3

Y1 - 2008/11/3

N2 - Lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) is among the most common malignant lymphomas of the ocular adnexa and it furthermore shows an increasing incidence. The disease is most often localized and indolent of nature; gentle treatment is therefore of essence to avoid complications, especially visual impairment. MALT lymphoma can be treated with radiotherapy (RT), but in case of relapse, alternatives are required. New treatment modalities such as anti-cluster of differentiation (CD)-20 monoclonal antibodies (rituximab) and local injection of interferon-alpha have shown promising results.

AB - Lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) is among the most common malignant lymphomas of the ocular adnexa and it furthermore shows an increasing incidence. The disease is most often localized and indolent of nature; gentle treatment is therefore of essence to avoid complications, especially visual impairment. MALT lymphoma can be treated with radiotherapy (RT), but in case of relapse, alternatives are required. New treatment modalities such as anti-cluster of differentiation (CD)-20 monoclonal antibodies (rituximab) and local injection of interferon-alpha have shown promising results.

UR - https://www.scopus.com/pages/publications/55949097449

M3 - Tidsskriftartikel

C2 - 18986616

SN - 1399-4174

VL - 170

SP - 3660

EP - 3663

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 45

ER -

Ekstranodalt marginalzonelymfom i øjets adnexa

Abstract

Other files and links

Fingerprint

Cite this